Navigation Links
Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
Date:9/28/2010

eagher & Flom LLP are acting as Endo's legal counsel.  JPMorgan Chase Bank N.A. and RBC Capital Markets are providing financing commitments.

J.P. Morgan Securities LLC is acting as exclusive financial advisor to Qualitest Pharmaceuticals and Kirkland & Ellis LLP are acting as Qualitest Pharmaceuticals' legal counsel.  

Conference Call and Webcast InformationEndo's management team will host a conference call and audio webcast on Tuesday, September 28 at 8:30 a.m. EDT to discuss this transaction. Interested parties may call 866-356-3095 (domestic) or 617-597-5391 (international) and enter code 18751869. Please dial in 15 minutes prior to the scheduled start time. A replay of the call will be available until 11:59 p.m. EDT on October 12 by dialing 888-286-8010 (domestic) or 617-801-6888 (international), passcode 52263898.

A simultaneous audio Webcast of the call may be accessed by visiting www.endo.com. A replay of the Webcast will be available until 11:59 p.m. EDT on October 12. The replay can be accessed by clicking on "Events" in the Investor Relations section of the Website. Please connect to the Website at least 15 minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.Reconciliation of Projected GAAP Diluted Earnings Per Share to Adjusted Diluted Earnings Per Share GuidanceYear EndingDecember 31, 2010Projected GAAP diluted income per common share$1.88To$1.96 Upfront and milestone-related payments to partners

$0.38 $0.33 Amortization of commercial intangible assets

$0.59 $0.59 Costs incurred in connection with continued efforts to enhance the cost structure of the Company

$0.08$0.08Indevus related costs and change in fair value of contingent consideration

$0.01$0.01Impairment of indefinite-lived intangibles

$0.11$0.11Costs related to the acquisition of HealthTronics, Inc.

$0.30$0
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... JOSE, Calif. , May 26, 2015  SI-BONE, ... of the iFuse Implant System, a minimally invasive surgical ... the sacroiliac (SI) joint, announced today that Laura ... officer effective immediately.   Ms. Francis joins the executive management ... and private companies in executive leadership positions.  ...
(Date:5/26/2015)... MARLBOROUGH, Mass. , May 26, 2015 ... ), a biotechnology company focused on discovering ... areas of dermatology and ophthalmology, today announced that ... Geert Cauwenbergh , will present at the ... June 4, 2015 at 11:30 a.m. EDT. ...
(Date:5/26/2015)... , May 26, 2015  InMed Pharmaceuticals ... that it has filed a provisional patent application ... ("USPTO") relating to the treatment of Epidermolysis Bullosa ... compounds developed by InMed. Dr. ... Officer, commented, "We are excited to file our ...
Breaking Medicine Technology:SI-BONE, Inc. Appoints Laura Francis Chief Financial Officer and Closes Additional Round of Growth Capital 2SI-BONE, Inc. Appoints Laura Francis Chief Financial Officer and Closes Additional Round of Growth Capital 3SI-BONE, Inc. Appoints Laura Francis Chief Financial Officer and Closes Additional Round of Growth Capital 4RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 2RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 3RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 4InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 2InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 3
... Medical Inc. (TMI),announced today that it has been ... commercialize in Europe the Antares(TM) Coronary,Stent System, a ... use,at or near coronary bifurcations., Representing the ... potential use in a quarter of the 2.2 ...
... Line Clinical Results Expected in November 2008, BOTHELL, ... ) announced today the completion of patient enrollment and ... evaluate the safety and,efficacy of its formulation of 12-hour ... expects to report top-line,results from this pivotal trial in ...
Cached Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3
(Date:5/26/2015)... NC (PRWEB) May 26, 2015 ... compliance solutions for the health and human services market, ... to meet demand. After strong attendance and participation in ... groups, and give their annual user conference an exciting ... Relias customers to come together and discuss best practices, ...
(Date:5/26/2015)... MD (PRWEB) May 26, 2015 ... marijuana. According to an article published by ... synthetic marijuana (dubbed K2, Spice, and black mamba) ... composition of these synthetic substances make it nearly ... confirm patients’ use of the substance due to ...
(Date:5/26/2015)... 26, 2015 Pasadena porcelain veneers ... dental cleanings with cosmetic treatments. Cosmetic dentistry is becoming ... Dentistry , “We are committed to providing you with ... outstanding customer service and a smile of a lifetime ... your smiles but to change your life,” explains Dr. ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 ... Indosoft's contact center ACD system to drop Asterisk 1.4 ... such trunk features as diversion headers, added Lyra support ... upgrades to warm transfers to improve information ...
(Date:5/26/2015)... May 26, 2015 National Prevention Week ... year. It is supported by the Substance Abuse ... raising public awareness of, and action about, substance abuse ... organizations and coalitions are encouraged to join in promoting ... and related issues, and in building community partnerships. , ...
Breaking Medicine News(10 mins):Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3
... ... Speaks at Gladys B. Jacobs Manor, in North Central Philadelphia , ... Philadelphia, PA (Vocus) October 28, 2009 ... Latina ever appointed to that position, recently spoke at the Original Richard Allen Committee’s ...
... /PRNewswire/ - LPBP Inc. (the "Company") announces a ... related to the per share dividend payable on ... dividend on the Class B Non-Voting shares should ... A Common shares of $0.0099 per share remains ...
... Oct. 28 In response to rising suicide and ... dedicated to supporting marriages and families, will present its ... to military couples in Milwaukee from Nov. 6 - 8 ... Weekend to Remember is a marriage getaway aimed ...
... California religious and community leaders, who have witnessed first ... well as the homeless, sick and mentally ill, gathered ... legalizing marijuana sales and use in California. , ... numerous faiths and religious denominations, were joined by community ...
... in tissue damage caused by smoking , WEDNESDAY, Oct. ... therapy for injured lungs that were previously rejected for ... transplant, researchers say. , Successful transplants require healthy lungs, ... highly inflamed and only mildly functional, which means many ...
... 28 If we get a boo-boo, we might know to ... kiss it and make it all better. But, what if ... us who aren,t prepared for dental emergencies can quickly get back ... Company at: , http://inr.mediaseed.tv/oneClip_C/?feed=Ss8P5Rb1iQulYDAELUR0M_kpwKp_6YSM , Medialink ...
Cached Medicine News:Health News:Head of PA Department of Aging Speaks at the Richard Allen Committee's 17th Annual Senior Citizen's Event 2Health News:FamilyLife Supports Military Marriages in Milwaukee 2Health News:Faith-Based Leaders and Community Activists Converge on State Capitol to Oppose Legalized Marijuana 2Health News:Faith-Based Leaders and Community Activists Converge on State Capitol to Oppose Legalized Marijuana 3Health News:Repairing Injured Lungs May Boost Organ Donations 2
... Cell-Chex is a spinal and body fluid ... When stained in the same manner as ... can be differentiated. The two-level control is ... white blood cell differential, as well as ...
... is a gene expression ... the risk of metastasis ... It is based on ... the Netherlands Cancer Institute ...
Antelys Peek Lumbar Technologies provides a range of varied heights and angles to correct lumbar lordosis and the associated sagital balance....
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Medicine Products: